PHC Holdings Corporation appoints independent external directors

KUALA LUMPUR, July 28 -- PHC Holdings Corporation (PHCHD), a leading global healthcare company, has announced the appointment of Alan Malus and Kyoko (Kay) Deguchi as independent external directors, effective June 30.

According to a statement, both bring extensive knowledge of the healthcare industry and executive-level experience at international and Japan-based medical device and life sciences companies.

President and Chief Executive Officer of PHCHD and Chairman of the Board of Directors for PHCHD, John Marotta said: "I am delighted to welcome Alan and Kay to the PHC Holdings Board of Directors and we are thrilled to have attracted people of their calibre to our board.”

Malus, who will serve as the lead independent external director, joins the board with over 18 years’ experience in the life sciences and diagnostics industry.

He was most recently Corporate Executive Vice President at Thermo Fisher Scientific Inc and the President of their Laboratory Products and Services Segment. His early career started with almost 15 years in the automotive industry, working for Ford, Chrysler and Textron.

Meanwhile, Deguchi joins the board with over 20 years’ experience in the healthcare and chemical industries, most recently running the Ochanomizu Orthopaedic Rehabilitation Clinic as Vice Director and currently serves as an outside director of several public and private companies, including Nippon Ski Resort Dev Co Ltd.

She has held a number of senior leadership positions in finance, marketing and operations for the Japanese subsidiaries of various international healthcare companies, including Janssen Pharmaceutical, Stryker and Abbvie.

More details at www.phchd.com.

-- BERNAMA